fructose 6-phosphate | 41452-28-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: fructose 6-phosphate
• 英文别名: 6-O-Phosphono-Alpha-D-Fructofuranose；[(2R,3S,4S,5S)-3,4,5-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl dihydrogen phosphate
• CAS: 41452-28-2
• 化学式: C₆H₁₃O₉P
• 分子量: 260.138
• InChiKey: BGWGXPAPYGQALX-ZXXMMSQZSA-N

物化性质

• 沸点：
  591.6±60.0 °C(Predicted)
• 密度：
  1.936±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -3.9
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  157
• 氢给体数：
  6
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  fructose 6-phosphate 在 nicotinamide adenine dinucleotide phosphate 、 magnesium chloride 、 glucose 6-phosphate dehydrogenase 作用下， 生成 Α-D-吡喃葡萄糖6-磷酸
  参考文献：
  名称：

  A New Complex of the Ribozyme with Glucose-6-Phosphate Isomerase Activity and the Enzyme Hexokinase in Baker’s Yeast Saccharomyces cerevisiae

  摘要：

  DOI：

  10.1134/s1068162023050084
• 作为产物：
  描述：

  Α-D-吡喃葡萄糖6-磷酸 在 rabbit muscle aldolase 、 磷酸丙糖异构酶 、 phosphofructokinase 、 α-glycerophosphate dehydrogenase 、 5’-三磷酸腺苷 、 还原型辅酶Ⅰ 、 magnesium chloride 作用下， 生成 fructose 6-phosphate
  参考文献：
  名称：

  A New Complex of the Ribozyme with Glucose-6-Phosphate Isomerase Activity and the Enzyme Hexokinase in Baker’s Yeast Saccharomyces cerevisiae

  摘要：

  DOI：

  10.1134/s1068162023050084

文献信息

• Novel Thiazole Inhibitors of Fructose 1,6-Bishosphatase
  申请人：Dang Qun

  公开号：US20070225259A1

  公开（公告）日：2007-09-27

  Compounds of Formula I, their prodrugs and salts, their preparation and their uses are described.

  公式I的化合物，它们的前药和盐，它们的制备以及它们的用途被描述了。
• Characterization of a thermotolerant ROK-type mannofructokinase from Streptococcus mitis: application to the synthesis of phosphorylated sugars
  作者：Carine Vergne-Vaxelaire、Aline Mariage、Jean-Louis Petit、Aurélie Fossey-Jouenne、Christine Guérard-Hélaine、Ekaterina Darii、Adrien Debard、Stessy Nepert、Virginie Pellouin、Marielle Lemaire、Anne Zaparucha、Marcel Salanoubat、Véronique de Berardinis

  DOI：10.1007/s00253-018-9018-1

  日期：2018.7

  As proof of concept, 8 hexoses were phosphorylated in moderate to good yields, some of them described for the first time like L-sorbose-5-phosphate unusually phosphorylated in position 5. Its thermotolerance, its wide pH tolerance (from 7 to 10), and temperature range (> 85% activity between 40 and 70 °C) open the way to applications in the enzymatic synthesis of monophosphorylated hexoses.

  迄今为止，大多数已经表征且表现出激酶活性的“阻遏物，开放阅读框，激酶”（ROK）蛋白都以D-葡萄糖为底物。通过探索测序的细菌多样性，已鉴定出61个属于ROK家族的ATP依赖性激酶，并通过实验测定了其己糖的磷酸化程度。主要发现这些激酶是耐热的，并且对D-甘露糖和D-果糖具有高活性，对D-塔格糖具有显着的活性。其中，对中嗜性链球菌的炎症（称为ScrKmitis）的ATP依赖性激酶进行了生物化学表征，并对其底物谱进行了进一步研究。该酶对D-甘露糖和D-果糖的催化效率分别为1.5 106 s-1 M-1和2.7 105 s-1 M-1。但对D-塔格糖（3.5 102 s-1 M-1）和非天然单糖D-altrose（1.1 104 s-1 M-1）和D-塔洛糖（3.4 102 s-1 M-1）也是重要的。对所有己糖测得的比活度显示出对D系列优于L系列的立体偏好。作为概念证明，8己糖以中等到良好的产率
• Novel Phosphinic Acid-Containing Thyromimetics
  申请人：Erion Mark D.

  公开号：US20090028925A1

  公开（公告）日：2009-01-29

  The present invention relates to compounds of phosphonic acid-containing T3 mimetics and monoesters thereof, stereoisomers, pharmaceutically acceptable salts, co-crystals, and prodrugs thereof and pharmaceutically acceptable salts and co-crystals of the prodrugs, as well as their preparation and uses for preventing and/or treating metabolic diseases such as obesity, NASH, hypercholesterolemia and hyperlipidemia, as well as associated conditions such as atherosclerosis, coronary heart disease, impaired glucose tolerance, metabolic syndrome x and diabetes.

  本发明涉及含有磷酸基T3拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟拟
• ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND MEDICINAL APPLICATION
  申请人：Bhuniya Debnath

  公开号：US20100310493A1

  公开（公告）日：2010-12-09

  Acetamide derivatives, their stereoisomers, tautomers, prodrugs, pharmaceutically acceptable salts, polymorphs, solvates and formulations thereof for the prophylaxis, management, treatment, control of progression, or adjunct treatment of diseases and/or medical conditions where the activation of glucokinase would be beneficial, are disclosed. The disclosure also provides process of preparation of these acetamide derivatives.

  乙酰胺衍生物，它们的立体异构体、互变异构体、前药、药用可接受盐、多型体、溶剂合物及其配方，用于预防、管理、治疗、控制疾病和/或医疗状况的进展，或者作为激活葡萄糖激酶有益时的辅助治疗，已被披露。该披露还提供了这些乙酰胺衍生物的制备方法。
• [EN] THYROID HORMONE RECEPTOR AGONIST AND USE THEREOF<br/>[FR] AGONISTE DU RÉCEPTEUR DES HORMONES THYROÏDIENNES ET SON UTILISATION
  申请人：METABASIS THERAPEUTICS INC

  公开号：WO2017184811A1

  公开（公告）日：2017-10-26

  A thyroid hormone receptor agonist and its use in the treatment of a disease associated thyroid hormone receptor beta are described. The compound can be effective in lowering cholesterol with minimum or no adverse effects on the heart or thyroid hormone axis.

  描述了一种甲状腺激素受体激动剂及其在治疗与甲状腺激素受体β相关的疾病中的应用。该化合物可以有效降低胆固醇，对心脏或甲状腺激素轴的不良影响最小或没有。